DigitSTEM – a new, large Danish stem cell research initiative in the neurodegenerative and immuno-oncology fields. DigitSTEM is a four-year stem cell focused research collaboration between The Technical University of Denmark (DTU), University of Copenhagen and Bioneer A/S. The collaborating partners are: DTU Bioengineering, DTU Compute and DTU Health Tech, The Novo Nordisk Foundation [...]
Bioneer A/S announces a strategic collaboration with the National Biologics Facility (NBF) to commercialize their combined CRO services for mammalian expression of recombinant proteins. Copenhagen, September 16th, 2021. Bioneer A/S, a globally operating Danish specialty-CRO creating and commercializing innovative research service solutions for early stage drug development and in vitro modelling, announced today [...]
Bioneer is happy to announce that we will be participating in the Rare Diseases training course: Pluripotent stem cells for rare disease research: banking, data, application from October 25th to 27th in an online format. Rare disease (RD) is one area where national and international multidisciplinary collaborations are valuable to overcome some of [...]
Bioneer is delighted to participate to the 23rd Symposium "Signal Transduction at the Blood-Brain Barriers", held September 22-24, 2021, as a virtual symposium. The 23rd International Symposium "Signal Transduction at the Blood-Brain Barriers" was originally planned for September 2021 in Bari / Italy, but had to be postponed to September/October 2022. The Scientific [...]
Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease Authors: Ingrid Swanson Pultz (PvP Biologics, Inc), Malcolm Hill (PvP Biologics, Inc), Joanne M. Vitanza (PvP Biologics, Inc), Clancey Wolf (PvP Biologics, Inc), Lasse Saaby (Bioneer A/S), Tina Liu (Takeda Pharmaceuticals International Co), Peter Winkle (Anaheim Clinical Trials), [...]
Development of a fully human assay combining NGN2-inducible neurons co-cultured with iPSC-derived astrocytes amenable for electrophysiological studies Authors: Pei-Yu Shih (Janssen Pharmaceutica NV), Mohamed Kreir (Janssen Pharmaceutica NV), Devesh Kumar(Janssen Pharmaceutica NV), Frederik Seibt (Janssen Pharmaceutica NV), Francisco Pestana (Janssen Pharmaceutica NV), Benjamin Schmid (Bioneer A/S), Bjørn Holst (Bioneer A/S), Christian Clausen (Bioneer [...]
Detection of lncRNA by LNA-Based In Situ Hybridization in Paraffin-Embedded Cancer Cell Spheroids Authors: Boye Schnack Nielsen (BioneerA/S), Jesper Larsen (BioneerA/S), Jakob Høffding (BioneerA/S), Son Ly Nhat (BioneerA/S), Natasha Helleberg Madsen (BioneerA/S), Trine Møller (BioneerA/S), Bjørn Holst (BioneerA/S), Kim Holmstrøm (BioneerA/S) Published in Long Non-Coding RNAs in Cancer Abstract Cancer cell spheroids are [...]
Monocyte Infiltration and Differentiation in 3D Multicellular Spheroid Cancer Models Authors: Natasha Helleberg Madsen (Bioneer A/S), Boye Schnack Nielsen (Bioneer A/S), Son Ly Nhat (Bioneer A/S), Søren Skov (Department of Veterinary and Animal Sciences, University of Copenhagen), Monika Gad 1 (Bioneer A/S), Jesper Larsen (Bioneer A/S) Published in Pathogens Abstract Tumor-associated macrophages often correlate [...]
Efficacy of a novel antimicrobial hydrogel for eradication of Staphylococcus epidermidis, Staphylococcus aureus and Cutibacterium acnes from preformed biofilm and treatment performance in an in vivo MRSA wound model Authors: Troels Ronco (Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen), Maria F Aragao (Department of Veterinary [...]
Bioneer A/S udvider og søger derfor en laborant med bred molekylær- og cellebiologisk erfaring. Om Bioneer: Bioneer er en kontraktforskningsvirksomhed inden for det biomedicinske og bioteknologiske område. Bioneer A/S ejes af DTU og løser især opgaver for virksomheder, men arbejder også for hospitaler og universiteter, og deltager desuden i danske og udenlandske forskningssamarbejder. [...]
